BIOMERICA INC. - COMM

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis

21 Nov 2024 08:19:00 By Nasdaq GlobeNewswire

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

07 Nov 2024 09:09:00 By Nasdaq GlobeNewswire

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

30 Oct 2024 08:19:00 By Nasdaq GlobeNewswire

Biomerica Reports First Quarter Fiscal 2025 Financial Results

16 Oct 2024 09:00:00 By Nasdaq GlobeNewswire

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

04 Sep 2024 08:19:00 By Nasdaq GlobeNewswire

Biomerica Reports Fiscal 2024 Year End Results

29 Aug 2024 09:00:00 By Nasdaq GlobeNewswire

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

01 Jul 2024 07:47:00 By Nasdaq GlobeNewswire

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

13 May 2024 08:19:00 By Nasdaq GlobeNewswire

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

29 Apr 2024 08:19:00 By Nasdaq GlobeNewswire

Biomerica provides update on inFoods® IBS expansion

15 Apr 2024 07:47:00 By Nasdaq GlobeNewswire

Biomerica Reports Third Quarter 2024 Financial Results

12 Apr 2024 19:23:53 By Nasdaq GlobeNewswire

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

28 Mar 2024 08:19:00 By Nasdaq GlobeNewswire

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

21 Feb 2024 08:19:00 By Nasdaq GlobeNewswire

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

23 Jan 2024 08:19:00 By Nasdaq GlobeNewswire

Biomerica Reports Second Quarter 2024 Financial Results

16 Jan 2024 08:19:00 By Nasdaq GlobeNewswire

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

18 Dec 2023 07:47:00 By Nasdaq GlobeNewswire

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

10 Nov 2023 08:19:00 By Nasdaq GlobeNewswire

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

08 Nov 2023 08:19:00 By Nasdaq GlobeNewswire

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

13 Oct 2023 13:10:28 By Nasdaq GlobeNewswire

Biomerica Reports First Quarter 2024 Financial Results

13 Oct 2023 06:39:00 By Nasdaq GlobeNewswire